These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29668748)

  • 41. Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol.
    Gama E; Madan J; Langley I; Girma M; Evans D; Rosen S; Squire SB
    BMJ Open; 2016 Oct; 6(10):e014386. PubMed ID: 27798041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
    Judge D; Krause V
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005-2010.
    Moore BK; Anyalechi E; van der Walt M; Smith S; Erasmus L; Lancaster J; Morris S; Ndjeka N; Ershova J; Ismail N; Burton D; Menzies H
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):663-9. PubMed ID: 25946356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis.
    Masuku SD; Berhanu R; Van Rensburg C; Ndjeka N; Rosen S; Long L; Evans D; Nichols BE
    Int J Tuberc Lung Dis; 2020 Apr; 24(4):376-382. PubMed ID: 32317060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.
    Sinanovic E; Floyd K; Dudley L; Azevedo V; Grant R; Maher D
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S56-62. PubMed ID: 12971655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
    Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing Local Risk of Rifampicin-Resistant Tuberculosis in KwaZulu-Natal, South Africa Using Lot Quality Assurance Sampling.
    Heidebrecht CL; Podewils LJ; Pym A; Mthiyane T; Cohen T
    PLoS One; 2016; 11(4):e0153143. PubMed ID: 27050561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia--an observational cohort study.
    Meressa D; Hurtado RM; Andrews JR; Diro E; Abato K; Daniel T; Prasad P; Prasad R; Fekade B; Tedla Y; Yusuf H; Tadesse M; Tefera D; Ashenafi A; Desta G; Aderaye G; Olson K; Thim S; Goldfeld AE
    Thorax; 2015 Dec; 70(12):1181-8. PubMed ID: 26506854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Towards understanding the drivers of policy change: a case study of infection control policies for multi-drug resistant tuberculosis in South Africa.
    Saidi T; Salie F; Douglas TS
    Health Res Policy Syst; 2017 May; 15(1):41. PubMed ID: 28558838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
    Floyd K; Hutubessy R; Kliiman K; Centis R; Khurieva N; Jakobowiak W; Danilovits M; Peremitin G; Keshavjee S; Migliori GB
    Eur Respir J; 2012 Jul; 40(1):133-42. PubMed ID: 22362862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergence of multidrug-resistant tuberculosis in a community-based directly observed treatment programme in rural South Africa.
    Davies GR; Pillay M; Sturm AW; Wilkinson D
    Int J Tuberc Lung Dis; 1999 Sep; 3(9):799-804. PubMed ID: 10488888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost of three models of care for drug-resistant tuberculosis patients in Nigeria.
    Bada FO; Okpokoro E; Blok N; Meribole E; Dutt S; Dakum P; Abimiku A; Zwerling A; Kik SV
    BMC Infect Dis; 2019 Jan; 19(1):41. PubMed ID: 30630429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
    PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa.
    Stephens F; Gandhi NR; Brust JCM; Mlisana K; Moodley P; Allana S; Campbell A; Shah S
    J Acquir Immune Defic Syndr; 2019 Oct; 82(2):124-130. PubMed ID: 31513073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.
    van den Hof S; Collins D; Hafidz F; Beyene D; Tursynbayeva A; Tiemersma E
    BMC Infect Dis; 2016 Sep; 16(1):470. PubMed ID: 27595779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful Tuberculosis Treatment Outcomes among HIV/TB Coinfected Patients Down-Referred from a District Hospital to Primary Health Clinics in Rural South Africa.
    Jacobson KB; Moll AP; Friedland GH; Shenoi SV
    PLoS One; 2015; 10(5):e0127024. PubMed ID: 25993636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
    Bastard M; Sanchez-Padilla E; du Cros P; Khamraev AK; Parpieva N; Tillyashaykov M; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Perez SF; Telnov A; Hewison C; Varaine F; Bonnet M
    PLoS One; 2018; 13(3):e0193491. PubMed ID: 29518098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial.
    Madan JJ; Rosu L; Tefera MG; van Rensburg C; Evans D; Langley I; Tomeny EM; Nunn A; Phillips PP; Rusen ID; Squire SB;
    Bull World Health Organ; 2020 May; 98(5):306-314. PubMed ID: 32514196
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.